Difference between revisions of "Korzh Stanislava"
From Bioblast
Tindle Lisa (talk | contribs) (Created page with "{{Person |lastname=Korzh |firstname=Stanislava |title=MSc. |institution= Latvian Institute of Organic Synthesis, LV |address= Aizkraukles Str 21 |area code=LV-1006 |ci...") ย |
Tindle Lisa (talk | contribs) |
||
Line 24: | Line 24: | ||
== Participated at == | == Participated at == | ||
::::* [[FAT4BRAIN Workshop IOC151 Innsbruck AT]] | |||
::::* [[FAT4BRAIN O2k-Workshop IOC148 Virtual Event]] | ::::* [[FAT4BRAIN O2k-Workshop IOC148 Virtual Event]] | ||
{{Labelingperson}} | {{Labelingperson}} |
Revision as of 11:31, 1 March 2023
Name | Korzh Stanislava, MSc. |
---|---|
Institution | Latvian Institute of Organic Synthesis, LV |
Address | Aizkraukles Str 21, LV-1006 |
City | Riga |
State/Province | |
Country | Latvia |
[email protected] | |
Weblink | |
O2k-Network Lab | LV Riga Liepins E |
Participated at
Labels:
Publications
Published | Reference | |
---|---|---|
Al-Sabri 2024 Sci Rep | 2024 | Al-Sabri MH, Ammar N, Korzh S, Alsehli AM, Hosseini K, Fredriksson R, Mwinyi J, Williams MJ, Boukhatmi H, Schiรถth HB (2024) Fluvastatin-induced myofibrillar damage is associated with elevated ROS, and impaired fatty acid oxidation, and is preceded by mitochondrial morphological changes. https://doi.org/10.1038/s41598-024-53446-w |
Cecatto 2023 MitoFit | 2023 | Cecatto C, Cardoso LHD, Ozola M, Korzh S, Zvejniece L, Gukalova B, Doerrier C, Dambrova M, Gnaiger E, Makrecka-Kuka M, Liepinsh E (2023) Fatty acid ฮฒ-oxidation in brain mitochondria: Insights from high-resolution respirometry in mouse, rat and Drosophila brain, ischemia and aging models. MitoFit Preprints 2023.10. https://doi.org/10.26124/mitofit:2023-0010 |
Makrecka-Kuka 2020 Cardiovasc Drugs Ther | 2020 | Makrecka-Kuka Marina, Korzh Stanislava, Videja Melita, Vilks Karlis, Cirule Helena, Kuka Janis, Dambrova Maija, Liepinsh Edgars (2020) Empagliflozin protects cardiac mitochondrial fatty acid metabolism in a mouse model of diet-induced lipid overload. Cardiovasc Drugs Ther 34:791-97. |